The store will not work correctly when cookies are disabled.
ethyl 4-(4-hydroxybut-1-ynyl)-6-methoxyquinoline-2-carboxylate
ID: ALA4640650
PubChem CID: 156014867
Max Phase: Preclinical
Molecular Formula: C17H17NO4
Molecular Weight: 299.33
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)c1cc(C#CCCO)c2cc(OC)ccc2n1
Standard InChI: InChI=1S/C17H17NO4/c1-3-22-17(20)16-10-12(6-4-5-9-19)14-11-13(21-2)7-8-15(14)18-16/h7-8,10-11,19H,3,5,9H2,1-2H3
Standard InChI Key: VMDQIBPEBLXQMC-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
27.7129 -1.9563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7118 -2.7758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4198 -3.1848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4180 -1.5474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1267 -1.9527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1274 -2.7717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8359 -3.1787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5442 -2.7679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5395 -1.9458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8304 -1.5424 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.2447 -1.5329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9549 -1.9372 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.2397 -0.7157 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.6601 -1.5243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3703 -1.9286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0037 -3.1838 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.2964 -2.7747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8376 -3.9959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8316 -4.8123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8256 -5.6295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5302 -6.0433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2409 -5.6400 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
9 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
14 15 1 0
2 16 1 0
16 17 1 0
7 18 1 0
18 19 3 0
19 20 1 0
20 21 1 0
21 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 299.33 | Molecular Weight (Monoisotopic): 299.1158 | AlogP: 2.15 | #Rotatable Bonds: 4 |
Polar Surface Area: 68.65 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 1.30 | CX LogP: 2.51 | CX LogD: 2.51 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.69 | Np Likeness Score: -0.54 |
References
1. Costa CA, Lopes RM, Ferraz LS, Esteves GNN, Di Iorio JF, Souza AA, de Oliveira IM, Manarin F, Judice WAS, Stefani HA, Rodrigues T.. (2020) Cytotoxicity of 4-substituted quinoline derivatives: Anticancer and antileishmanial potential., 28 (11): [PMID:32336669] [10.1016/j.bmc.2020.115511] |